TrialX
Image

A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Testing BI 771716 for advanced AMD called Geographic Atrophy.

Recruiting
50 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is for people aged 50 or older with **geographic atrophy (GA)**, an advanced form of **age-related macular degeneration (AMD)**. AMD is a condition that affects the eyes, causing vision loss. The study compares two medications: BI 771716, which is under investigation, and pegcetacoplan, which is already used for GA. Participants will receive eye injections every 4 weeks for a little over a year. Doctors will check participants' eyes and overall health regularly.

  • **Age Requirement**: Must be at least 50 years old.
  • **Study Duration**: Lasts just over a year with visits every 4 weeks.
  • **Key Conditions**: Must have GA from AMD and meet specific eye health criteria.

If you have previously received certain treatments or have other specific eye conditions, you may not qualify. This study aims to see how well the investigational medication works compared to the existing one. Always consult with your healthcare provider before deciding to join a study.

Study details
    Macular Degeneration
    Age-related
    Geographic Atrophy

NCT06722157

Boehringer Ingelheim

17 February 2025

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.